Articles By Anuja Singh
Can Novo Nordisk’s AI Partnership with AWS Transform the Drug Discovery Timeline?
Copenhagen/London, August 2026 — Novo Nordisk and Amazon Web Services (AWS) have entered into a strategic partnership aimed…
By
OmniAb and Eli Lilly Announce $370M Global Collaboration to Discover Antibody-Based Therapeutics Targeting Ion…
Emeryville, Calif. and Indianapolis, Ind. — August 17, 2026 — OmniAb, Inc. (NASDAQ: OABI), a leading provider of…
Sandoz’s $314M Bet on Chinese Biosimilars Targets a Drug the Industry Couldn’t Crack for…
Inside the Sandoz-Henlius licensing deal for biosimilars of Repatha, Benlysta, and Erbitux — and why one of the…
Merck and Moderna’s Melanoma Vaccine Win Could Be the Proof Point mRNA Oncology Has…
What the Phase 3 intismeran autogene + Keytruda results mean for the next wave of personalized cancer vaccines…
Prosper Medical’s $16M Raise Is a Bet That AI Can Make Concierge Medicine Affordable…
Analysis of Prosper Medical’s seed round, its AI-powered care model, and what it signals about the next phase…
The FDA Just Created a Reimbursement Pathway for AI-Driven Care — Here’s Why That…
Analysis of the FDA’s TEMPO pilot, its first AI-enabled participant, and what it signals for how algorithmic health…
Can Novo Nordisk’s AI Partnership with AWS Transform the Drug Discovery Timeline?
Copenhagen/London, August 2026 — Novo Nordisk and Amazon Web Services (AWS) have entered into a strategic partnership aimed…
OmniAb and Eli Lilly Announce $370M Global Collaboration to Discover Antibody-Based Therapeutics Targeting Ion…
Emeryville, Calif. and Indianapolis, Ind. — August 17, 2026 — OmniAb, Inc. (NASDAQ: OABI), a leading provider of…
Sandoz’s $314M Bet on Chinese Biosimilars Targets a Drug the Industry Couldn’t Crack for…
Inside the Sandoz-Henlius licensing deal for biosimilars of Repatha, Benlysta, and Erbitux — and why one of the…
Merck and Moderna’s Melanoma Vaccine Win Could Be the Proof Point mRNA Oncology Has…
What the Phase 3 intismeran autogene + Keytruda results mean for the next wave of personalized cancer vaccines…
Prosper Medical’s $16M Raise Is a Bet That AI Can Make Concierge Medicine Affordable…
Analysis of Prosper Medical’s seed round, its AI-powered care model, and what it signals about the next phase…
The FDA Just Created a Reimbursement Pathway for AI-Driven Care — Here’s Why That…
Analysis of the FDA’s TEMPO pilot, its first AI-enabled participant, and what it signals for how algorithmic health…